Vice President of Clinical Affairs
With more than 10 years of experience managing all phases of clinical research for medical devices, Mr. Marc Penna started with Intact Vascular in 2015 and Vesper Medical in 2016 and is responsible for creating short-and long-term clinical strategies with a focus on enhancing trial enrollment. He has held both executive and clinical data/clinical trial program management roles within the cardiovascular, endovascular and oncology therapeutic areas. Previously, he served as the Senior Director of Clinical and Medical Affairs at AngioDynamics, where he was responsible for all global clinical activity. Earlier in his career, Mr. Penna worked on the transcatheter aortic valve replacement (TAVR) pivotal trials at Edwards Life Sciences as well as on the drug eluting stent program at Boston Scientific. Mr. Penna holds a B.S. in Management Information Systems from Central Connecticut State University.